Publications

Roller-Wirnsberger RElisabeth, van den Noortgate N, Bonin-Guillaume S, Andersen-Ranberg K, Ranhoff AHylen, Münzer T, Grodzicki T, Conroy S, Landi F, Mieiro L et al..  2018.  Setting competencies and standards for a European Leadership Program in Geriatric Medicine: "The European Academy for Medicine of Ageing (EAMA) reloaded".. Eur Geriatr Med. 9(3):399-406.

Laurens B, Planche V, Cubizolle S, Declerck L, Dupouy S, Formaglio M, Koric L, Seassau M, Tilikete C, Vighetto A et al..  2019.  A Spatial Decision Eye-Tracking Task in Patients with Prodromal and Mild Alzheimer's Disease.. J Alzheimers Dis. 71(2):613-621.

Vonk JMJ, Bouteloup V, Mangin J-F, Dubois B, Blanc F, Gabelle A, Ceccaldi M, Annweiler C, Krolak-Salmon P, Belin C et al..  2020.  Semantic loss marks early Alzheimer's disease-related neurodegeneration in older adults without dementia.. Alzheimers Dement (Amst). 12(1):e12066.

Sacco G, Brière O, Asfar M, GuÉrin O, Berrut G, Annweiler C.  2020.  [Symptoms of COVID-19 among older adults: systematic review of biomedical literature].. Geriatr Psychol Neuropsychiatr Vieil. 18(2):135-140.

Janczyk EMagdalena, Champigny N, Michel E, Raffaelli C, Annweiler C, Zory R, GuÉrin O, Sacco G.  2021.  Sonoelastography to Assess Muscular Stiffness Among Older Adults and its Use for the Diagnosis of Sarcopenia: A Systematic Review.. Ultraschall Med. 42(6):634-642.

Grelier L, Baboudjian M, Gondran-Tellier B, Couderc A-L, McManus R, Deville J-L, Carballeira A, Delonca R, Delaporte V, Padovani L et al..  2021.  Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience.. Cancers (Basel). 13(13)

Hellec J, Chorin F, Castagnetti A, GuÉrin O, Colson SS.  2022.  Smart Eyeglasses: A Valid and Reliable Device to Assess Spatiotemporal Parameters during Gait.. Sensors (Basel). 22(3)

Boisteau E, François E, Aparicio T, Le Malicot K, Boulahssass R, Lecomte T, Laurent-Puig P, Guiu B, Paillaud E, Galais M-P et al..  2022.  SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.. Dig Liver Dis. 54(6):747-754.